ArticleCancer discovery2019
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells.
Tamilla Nechiporuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
251 papers cite itlatest 60 shown
this paperpooled ittrialcites it